hat
Methyltrienolone se yon esteroyid oral aplikab, ki te deja devlope nan ane 1960 yo pou yo itilize nan bèt ak eksperyans selil yo. Te sentèz la premye dekri nan 1963.Methyltrienolone travay nan ogmante agressions la ak Se poutèt sa motivasyon an nan atlèt la pou yo ale nan limit li nan fòmasyon. Li te tou diminye tan an rejenerasyon. Yon atlèt bezwen pi kout repo epi li ka tren pi souvan. Paske methyltrienolone pa ka konvèti nan estwojèn pa anzim nan aromatase akòz estrikti li yo nan kò a, depo dlo vle elimine. Pou rezon sa a, methyltrienolone yo itilize pou preparasyon konpetisyon oswa rejim alimantè.
eng
Methyltrienolone is an orally applicable steroid, which was already developed in the 1960s for use in animal and cell experiments. The synthesis was first described in 1963.Methyltrienolone works by increasing the aggressiveness and therefore the motivation of the athlet to go to his limits in training. It also decreases the regeneration time. An athlete needs shorter breaks and can train more often. Because methyltrienolone can not be converted into estrogen by the aromatase enzyme due to its structure in the body, unwanted water storage is eliminated. For this reason, methyltrienolone is used for competition preparation or diet.